Add like
Add dislike
Add to saved papers

Gaboon viper envenomation: An unexpected injury by non-indigenous snake in South Korea.

In recent years, various kinds of non-indigenous snakes have become popular as domestic pets globally. If the snake is highly venomous, this would be a potentially life-threatening emergency for breeders. In such a case, the specific antidote should be administered immediately for saving the life. "Salmusa" genus (e.g. Gloydius genus) is a representative indigenous venomous snake in South Korea. Therefore, only one antidote for the "Salmusa" genus is commercially available in South Korea. The Gaboon viper ( Bitis gabonica ) inhabits in the rainforests of sub-Saharan Africa. Its venom is very toxic for mammals. Victims of a Gaboon viper bite could result in die unless the appropriate antidote is administered timely. We report a case of a 20-year-old male who completely recovered from a Gaboon viper envenomation after receiving "Salmusa" antivenom (Kovax® ). This report reminds us that establishing an inventory of antidotes for potential toxic non-indigenous organisms is needed to enable successful treatment of emergency situations for public health.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app